These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The Relationship between p-tau217, p-tau231, and p-tau205 in the Human Brain Is Affected by the Cellular Environment and Alzheimer's Disease Pathology. Wennström M; Schultz N; Gallardo PM; The Netherlands Brain Bank ; Serrano GE; Beach TG; Bose S; Hansson O Cells; 2024 Feb; 13(4):. PubMed ID: 38391945 [TBL] [Abstract][Full Text] [Related]
4. Mass spectrometric simultaneous quantification of tau species in plasma shows differential associations with amyloid and tau pathologies. Montoliu-Gaya L; Benedet AL; Tissot C; Vrillon A; Ashton NJ; Brum WS; Lantero-Rodriguez J; Stevenson J; Nilsson J; Sauer M; Rahmouni N; Brinkmalm G; Lussier FZ; Pascoal TA; Skoog I; Kern S; Zetterberg H; Paquet C; Gobom J; Rosa-Neto P; Blennow K Nat Aging; 2023 Jun; 3(6):661-669. PubMed ID: 37198279 [TBL] [Abstract][Full Text] [Related]
5. Ante-mortem plasma phosphorylated tau (181) predicts Alzheimer's disease neuropathology and regional tau at autopsy. Morrison MS; Aparicio HJ; Blennow K; Zetterberg H; Ashton NJ; Karikari TK; Tripodis Y; Martin B; Palmisano JN; Sugarman MA; Frank B; Steinberg EG; Turk KW; Budson AE; Au R; Goldstein LE; Jun GR; Kowall NW; Killiany R; Qiu WQ; Stern RA; Mez J; McKee AC; Stein TD; Alosco ML Brain; 2022 Oct; 145(10):3546-3557. PubMed ID: 35554506 [TBL] [Abstract][Full Text] [Related]
6. Head-to-head study of diagnostic accuracy of plasma and cerebrospinal fluid p-tau217 versus p-tau181 and p-tau231 in a memory clinic cohort. Mendes AJ; Ribaldi F; Lathuiliere A; Ashton NJ; Janelidze S; Zetterberg H; Scheffler M; Assal F; Garibotto V; Blennow K; Hansson O; Frisoni GB J Neurol; 2024 Apr; 271(4):2053-2066. PubMed ID: 38195896 [TBL] [Abstract][Full Text] [Related]
11. Phosphorylated tau in Alzheimer's disease. Telser J; Grossmann K; Wohlwend N; Risch L; Saely CH; Werner P Adv Clin Chem; 2023; 116():31-111. PubMed ID: 37852722 [TBL] [Abstract][Full Text] [Related]
12. Head-to-head comparison of 10 plasma phospho-tau assays in prodromal Alzheimer's disease. Janelidze S; Bali D; Ashton NJ; Barthélemy NR; Vanbrabant J; Stoops E; Vanmechelen E; He Y; Dolado AO; Triana-Baltzer G; Pontecorvo MJ; Zetterberg H; Kolb H; Vandijck M; Blennow K; Bateman RJ; Hansson O Brain; 2023 Apr; 146(4):1592-1601. PubMed ID: 36087307 [TBL] [Abstract][Full Text] [Related]
13. Plasma p-tau181 and p-tau217 in discriminating PART, AD and other key neuropathologies in older adults. Yu L; Boyle PA; Janelidze S; Petyuk VA; Wang T; Bennett DA; Hansson O; Schneider JA Acta Neuropathol; 2023 Jul; 146(1):1-11. PubMed ID: 37031430 [TBL] [Abstract][Full Text] [Related]
14. Comparison of Plasma Phosphorylated Tau Species With Amyloid and Tau Positron Emission Tomography, Neurodegeneration, Vascular Pathology, and Cognitive Outcomes. Mielke MM; Frank RD; Dage JL; Jeromin A; Ashton NJ; Blennow K; Karikari TK; Vanmechelen E; Zetterberg H; Algeciras-Schimnich A; Knopman DS; Lowe V; Bu G; Vemuri P; Graff-Radford J; Jack CR; Petersen RC JAMA Neurol; 2021 Sep; 78(9):1108-1117. PubMed ID: 34309632 [TBL] [Abstract][Full Text] [Related]
15. Plasma and CSF biomarkers in a memory clinic: Head-to-head comparison of phosphorylated tau immunoassays. Ashton NJ; Puig-Pijoan A; Milà-Alomà M; Fernández-Lebrero A; García-Escobar G; González-Ortiz F; Kac PR; Brum WS; Benedet AL; Lantero-Rodriguez J; Day TA; Vanbrabant J; Stoops E; Vanmechelen E; Triana-Baltzer G; Moughadam S; Kolb H; Ortiz-Romero P; Karikari TK; Minguillon C; Hernández Sánchez JJ; Navalpotro-Gómez I; Grau-Rivera O; María Manero R; Puente-Periz V; de la Torre R; Roquer J; Dage JL; Zetterberg H; Blennow K; Suárez-Calvet M Alzheimers Dement; 2023 May; 19(5):1913-1924. PubMed ID: 36370462 [TBL] [Abstract][Full Text] [Related]
18. Differences between ante mortem Alzheimer's disease biomarkers in predicting neuropathology at autopsy. Wang ZB; Tan L; Wang HF; Chen SD; Fu Y; Gao PY; Ma YH; Guo Y; Hou JH; Zhang DD; Yu JT; Alzheimers Dement; 2023 Aug; 19(8):3613-3624. PubMed ID: 36840620 [TBL] [Abstract][Full Text] [Related]
19. Clinical and analytical comparison of six Simoa assays for plasma P-tau isoforms P-tau181, P-tau217, and P-tau231. Bayoumy S; Verberk IMW; den Dulk B; Hussainali Z; Zwan M; van der Flier WM; Ashton NJ; Zetterberg H; Blennow K; Vanbrabant J; Stoops E; Vanmechelen E; Dage JL; Teunissen CE Alzheimers Res Ther; 2021 Dec; 13(1):198. PubMed ID: 34863295 [TBL] [Abstract][Full Text] [Related]
20. Comparing the Clinical Utility and Diagnostic Performance of CSF P-Tau181, P-Tau217, and P-Tau231 Assays. Leuzy A; Janelidze S; Mattsson-Carlgren N; Palmqvist S; Jacobs D; Cicognola C; Stomrud E; Vanmechelen E; Dage JL; Hansson O Neurology; 2021 Oct; 97(17):e1681-e1694. PubMed ID: 34493616 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]